Document Page: First | Prev | Next | All | Image | This Release | Search
File: 961031_950925_0503wp_00d.txtIraqi Nerve Agents Filename:0503wp.00d Subject: Iraqi Nerve Agents [ (b)(2) ] [ (b)(6) ] In response to your questions the following is submitted: 1A. [ (b)(1) sec 1.3(a)(4) ]DIA estimates on the number of Iraqi chemical warheads for SCUD missiles: DIA estimates that Iraq has 20-40 chemical warheads for its SCUD-B SSM's. A recent report [ (b)(1) sec 1.3(a)(4) ] that Iraq has 20 chemical warheads for its SCUD missiles, enough for five or six salvos employing chemical warheads. [ (b)(1) sec 1.3(a)(4) ] 1B. What is the basis for DIA's assessment that Iraqi nerve agents will be militarily ineffective after 31 March? Iraq is not able to make good-quality chemical agents. Technical failures have reduced their agent purity and caused problems in storage and handling. This is a particular problem for the sarin-type nerve agents (GB and GF). Lower purity causes internal decomposition of the agent, significantly limits shelf life and reduces toxic effects when the munition is employed. We estimate the shelf life of these nerve agents to be 4-6 weeks. Mustard and binary agents have somewhat longer shelf lives. Mustard is also judged to be of poor quality, but it has less corrosive impurities, thus a longer shelf life. The chemicals used in a binary weapon are not true chemical agents. They must mix while the munition is in flight and result in the toxic binary agent dispersed when the munition is burst. These precursor chemicals have lower toxicity, so they are easier to produce with good quality than unitary agents, and therefore have a longer shelf life. A chemical weapons production run probably was conducted at Samarra from mid-December 1990 through mid-January 1991. The nerve agent recently produced should have already begun to deteriorate, and decomposition should make most of the nerve agent weapons militarily ineffective by the end of March 1991. POC [ (b)(6) ][ (b)(2) ]
Document Page: First | Prev | Next | All | Image | This Release | Search